RT Book, Section
A1 Weiss, Robert A.
A1 Weiss, Margaret A.
A1 Beasley, Karen L.
SR Print(0)
ID 1175621272
T1 Foam Sclerotherapy
T2 Sclerotherapy and Vein Treatment, 2e
YR 2012
FD 2012
PB McGraw Hill LLC
PP New York, NY
SN 9780071485425
LK dermatology.mhmedical.com/content.aspx?aid=1175621272
RD 2024/10/03
AB Sclerotherapy  with  a  foamed  solution  has  become  the  standard  treatment  of  many  varicosities,  perforating  veins,  reticular  veins,  and  larger  telangiectasias  or  venulectasias  (1.0–2  mm).  Although  any  detergent  solution  may  be  agitated  with  air  and  foamed,  the  two  most  popular  solutions  that  are  typically  foamed  are  the  detergent  solutions,  sodium  tetradecyl  sulfate  (STS,  sold  in  the  United  States  as  Sotradecol®;  Bioniche  Pharma,  USA,  LLC,  Lake  Forest,  IL)  and  polidocanol  (POL,  sold  in  the  United  States  as  Asclera®;  Chemische  Fabrik  Kreussler  &  Co.,  GmbH,  Wiesbaden,  Germany).  Currently,  to  agitate  and  foam  these  U.S.  Food  and  Drug  administration  (FDA)-cleared  sclerosants  is  an  off-label  use  in  the  United  States.  Foaming  of  solutions  cannot  be  discussed  or  suggested  by  the  companies  manufacture  or  distribute  the  solutions  in  the  United  States  because  of  the  off-label  use  status.